Resistance, epigenetics and the cancer ecosystem

Nature Medicine

Volumn 17, Issue 3, 2011, Pages 288-289

  Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; HISTONE DEACETYLASE INHIBITOR; IMATINIB; SOMATOMEDIN C RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL SURVIVAL; CHROMATIN; CHRONIC MYELOID LEUKEMIA; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

CHROMATIN; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; NEOPLASMS;

EID: 79952377463     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0311-288     Document Type: Article

References (12)

1. Hoey, T. Sci. Transl. Med. 2, 28ps19 (2010).
2. Sawyers, C.L. Nat. Med. 15, 1158-1161 (2009).
3. Engelman, J.A. & Janne, P.A. Clin. Cancer Res. 14, 2895-2899 (2008).
4. Cohen, A.A. et al. Science 322, 1511-1516 (2008).
5. Bird, A. Genes Dev. 16, 6-21 (2002).
6. Sharma, S.V. et al. Cell 141, 69-80 (2010).
7. Jones, P.A. & Baylin, S.B. Cell 128, 683-692 (2007).
8. Reya, T., Morrison, S.J., Clarke, M.F. & Weissman, I.L. Nature 414, 105-111 (2001).
9. Klose, R.J. et al. Cell 128, 889-900 (2007).
10. Gaymes, T.J. et al. Mol. Cancer Res. 4, 563-573 (2006).
11. Johnstone, S.E. & Baylin, S.B. Nat. Rev. Genet. 11, 806-812 (2010).
12. Mikkelsen, T.S. et al. Nature 454, 49-55 (2008).